Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation
Phase of Trial: Phase I
Latest Information Update: 09 May 2016
At a glance
- Drugs Eltrombopag (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions
- 01 Apr 2016 Status changed from recruiting to completed.
- 14 Nov 2015 New trial record
- 26 Oct 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.